Dr Joanna Elson
Dr Ilse Pienaar
| A Novel Mitochondria-Targeting Iron Chelator Neuroprotects Multimodally via HIF-1 Modulation Against a Mitochondrial Toxin in a Dopaminergic Cell Model of Parkinson’s Disease | 2023 |
|
Dr Hilmar Sigurdsson
Heather Hunter
Dr Lisa Alcock
Ross Wilson
Dr Ilse Pienaar
et al. | Safety and tolerability of adjunct non-invasive vagus nerve stimulation in people with parkinson's: a study protocol | 2023 |
|
Dr Jannetta Steyn
Dr Ilse Pienaar
Dr Joanna Elson
| Mitochondrial DNA population variation is not associated with Alzheimer's in the Japanese population: A consistent finding across global populations | 2022 |
|
Dr Ilse Pienaar
Dr Joanna Elson
| Investigation of the Correlation Between Mildly Deleterious mtDNA Variations and the Clinical Progression of Multiple Sclerosis | 2021 |
|
Dr Joanna Elson
Dr Ilse Pienaar
| Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants | 2020 |
|
Dr Joanna Elson
Dr Meera Soundararajan
Dr Ilse Pienaar
| Novel 1-hydroxypyridin-2-one metal chelators prevent and rescue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson’s disease | 2020 |
|
Dr Cara Tomas
Dr Ilse Pienaar
Vicki Strassheim
Professor Fai Ng
Emerita Professor Julia Newton
et al. | MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants | 2019 |
|
Rebecca Brennan
Dr Ilse Pienaar
Professor Francois van der Westhuizen
Dr Joanna Elson
| The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects | 2019 |
|
Dr Joanna Elson
Dr Ilse Pienaar
| Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson’s Disease | 2018 |
|
Dr Ilse Pienaar
Dr Joanna Elson
| Mildly deleterious mitochondrial DNA variants are less frequent in healthy older individuals, but not more prevalent in Alzheimer’s patients | 2017 |
|
Alex Bury
Dr Angela Pyle
Dr Joanna Elson
Professor Laura Greaves
Dr Christopher Morris
et al. | Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson disease | 2017 |
|
Dr Ilse Pienaar
Dr Joanna Elson
| MutPred mutational load analysis shows mildly deleterious mitochondrial DNA variants are not more prevalent in Alzheimer's patients, but may be under-represented in healthy older individuals | 2017 |
|
Dr Ilse Pienaar
Dr Joanna Elson
Alex Bury
| An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease | 2015 |
|
Dr Ilse Pienaar
Dr Joanna Elson
Professor Raj Kalaria
| Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease | 2015 |
|
Dr Ilse Pienaar
Dr Sasha Gartside
Sabine Gretenkord
Dr Joanna Elson
| Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease | 2015 |
|
Dr Ilse Pienaar
Professor Patrick Chinnery
| Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression | 2013 |
|
Dr Ilse Pienaar
Dr Joanna Elson
Dr Claudia Racca
Dr Glyn Nelson
Emeritus Professor Doug Turnbull
et al. | Mitochondrial Abnormality Associates with Type-Specific Neuronal Loss and Cell Morphology Changes in the Pedunculopontine Nucleus in Parkinson Disease | 2013 |
|
Dr Carole Proctor
Dr Ilse Pienaar
Dr Joanna Elson
Emeritus Professor Thomas Kirkwood
| Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer's disease: A stochastic modelling approach | 2012 |
|
Dr Nichola Lax
Dr Ilse Pienaar
Dr Amy Reeve
Philippa Hepplewhite
Dr Evelyn Jaros
et al. | Microangiopathy in the cerebellum of patients with mitochondrial DNA disease | 2012 |
|
